Daiwa Securities Group Inc. Catalyst Pharmaceuticals, Inc. Call Options Transaction History
Daiwa Securities Group Inc.
- $17.7 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CPRX
# of Institutions
278Shares Held
95.8MCall Options Held
40.6KPut Options Held
67.2K-
Black Rock Inc. New York, NY17.7MShares$300 Million0.01% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY9.13MShares$155 Million3.01% of portfolio
-
State Street Corp Boston, MA8.15MShares$138 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.98MShares$135 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.74MShares$46.4 Million0.01% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $1.74B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...